4.89
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Low
1.43
High
10.9718
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cleveland BioLabs Inc | CBLI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 4.89 | 07:00:05 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.89 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 4.89 | 5.29 | 0.40 | - | - |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 4 | 31 | 389,901 | 1.43 - 10.9718 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:33:49 | 4 | $ 4.89 | USD |
Cleveland BioLabs Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 63.65M | 13.02M | 6.45M | $ 1.11M | $ - | -0.23 | -19.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Cleveland BioLabs News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CBLI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.96 | 6.13 | 4.58 | 5.01 | 125,314 | -1.07 | -17.95% |
| 1 Month | 5.59 | 7.17 | 4.58 | 6.09 | 187,102 | -0.70 | -12.52% |
| 3 Months | 4.64 | 10.9718 | 4.54 | 6.78 | 342,651 | 0.25 | 5.39% |
| 6 Months | 2.66 | 10.9718 | 2.3801 | 4.98 | 337,360 | 2.23 | 83.83% |
| 1 Year | 1.66 | 10.9718 | 1.43 | 3.52 | 1,164,857 | 3.23 | 194.58% |
| 3 Years | 2.80 | 10.9718 | 0.50 | 3.42 | 493,821 | 2.09 | 74.64% |
| 5 Years | 2.406 | 10.9718 | 0.50 | 3.58 | 378,711 | 2.48 | 103.24% |
Cleveland BioLabs Description
| Cleveland BioLabs Inc is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of Toll-like immune receptor activators has applications in the mitigation of radiation injury and immuno-oncology. Its lead product candidate is entolimod, an immuno-stimulatory agent, which is developed as a radiation countermeasure and immunotherapy for oncology and other indications. Entolimod is a Toll-like receptor 5 (TLR5) agonist, which is developed as a radiation countermeasure for prevention of death from Acute Radiation Syndrome (ARS), and as an oncology drug. |
